Fairview Capital Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,063
Closed -$746K 166
2024
Q4
$746K Sell
7,063
-28,779
-80% -$3.04M 0.04% 101
2024
Q3
$3.87M Sell
35,842
-72,899
-67% -$7.87M 0.21% 63
2024
Q2
$11.8M Sell
108,741
-1,729
-2% -$188K 0.66% 32
2024
Q1
$14.6M Buy
110,470
+24,657
+29% +$3.25M 0.82% 31
2023
Q4
$10.4M Sell
85,813
-2,998
-3% -$365K 0.62% 36
2023
Q3
$9.97M Sell
88,811
-17,382
-16% -$1.95M 0.64% 34
2023
Q2
$15.5M Buy
106,193
+300
+0.3% +$43.7K 0.98% 27
2023
Q1
$13.7M Buy
105,893
+2,664
+3% +$344K 0.89% 30
2022
Q4
$13.2M Sell
103,229
-2,828
-3% -$361K 0.9% 30
2022
Q3
$11.1M Buy
106,057
+7,160
+7% +$749K 0.79% 33
2022
Q2
$10.4M Buy
98,897
+926
+0.9% +$97.3K 0.72% 36
2022
Q1
$12.5M Buy
97,971
+74,553
+318% +$9.53M 0.78% 30
2021
Q4
$2.89M Buy
+23,418
New +$2.89M 0.18% 59